This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/news/525368-pakistan-covid-china-vaccine/
The article has changed 3 times. There is an RSS feed of changes available.
| Version 0 | Version 1 |
|---|---|
| Pakistan launches single-shot ‘PakVac’ Covid-19 jab developed by China’s CanSino | Pakistan launches single-shot ‘PakVac’ Covid-19 jab developed by China’s CanSino |
| (3 months later) | |
| Pakistan has launched a one-shot Covid-19 vaccine developed by China’s CanSino Biologics for use in adults aged over 18. Distributed under the label ‘PakVac’, the jab is to be produced domestically down the line, officials said. | Pakistan has launched a one-shot Covid-19 vaccine developed by China’s CanSino Biologics for use in adults aged over 18. Distributed under the label ‘PakVac’, the jab is to be produced domestically down the line, officials said. |
| In a nod to the vaccine’s developers, Special Assistant to Prime Minister (SAPM) on Health Faisal Sultan praised China for its partnership in the creation of the vaccine. | In a nod to the vaccine’s developers, Special Assistant to Prime Minister (SAPM) on Health Faisal Sultan praised China for its partnership in the creation of the vaccine. |
| “China was already a friend and came forward when Covid-19 [hit Pakistan],” he added. | “China was already a friend and came forward when Covid-19 [hit Pakistan],” he added. |
| Speaking at a special launch ceremony in Islamabad, Sultan said Pakistan would shortly be able to start producing PakVac itself, noting that manufacturing a vaccine from raw materials was no mean feat. The official also said the vaccine – which is administered as a single shot – has passed all the relevant tests and is safe and effective against Covid-19. | Speaking at a special launch ceremony in Islamabad, Sultan said Pakistan would shortly be able to start producing PakVac itself, noting that manufacturing a vaccine from raw materials was no mean feat. The official also said the vaccine – which is administered as a single shot – has passed all the relevant tests and is safe and effective against Covid-19. |
| Last week, Sultan congratulated the country’s National Institute of Health for successfully carrying out ‘fill and finish’ operations – the final stage of production – for the vaccine. | Last week, Sultan congratulated the country’s National Institute of Health for successfully carrying out ‘fill and finish’ operations – the final stage of production – for the vaccine. |
| The CanSino Biologics jab has so far been given approval for use in Chile, China, Hungary, Mexico, Moldova and Pakistan. According to officials in Pakistan, analysis of interim trial data suggested the vaccine was 65.7% effective in preventing symptomatic Covid-19. | The CanSino Biologics jab has so far been given approval for use in Chile, China, Hungary, Mexico, Moldova and Pakistan. According to officials in Pakistan, analysis of interim trial data suggested the vaccine was 65.7% effective in preventing symptomatic Covid-19. |
| Stage three trials were carried out in Pakistan, Saudi Arabia and Mexico. The data also suggest the shot is 90.98% in preventing severe Covid-19. | Stage three trials were carried out in Pakistan, Saudi Arabia and Mexico. The data also suggest the shot is 90.98% in preventing severe Covid-19. |
| If you like this story, share it with a friend! | If you like this story, share it with a friend! |
| Dear readers and commenters, | |
| We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system. | |
| Sorry for the inconvenience, and looking forward to your future comments, | |
| RT Team. |